ADRA2A Gene

ADRA2A Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ADRA2A Gene</th>
</tr>
<tr>
<td class="label">Drug</td>
<td>Use</td>
</tr>
<tr>
<td class="label">Clonidine</td>
<td>Hypertension, ADHD</td>
</tr>
<tr>
<td class="label">Guanfacine</td>
<td>Hypertension, ADHD</td>
</tr>
<tr>
<td class="label">Dexmedetomidine</td>
<td>Sedation</td>
</tr>
<tr>
<td class="label">Brimonidine</td>
<td>Glaucoma</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Use</td>
</tr>
<tr>
<td class="label">Yohimbine</td>
<td>Reversal of α2 blockade</td>
</tr>
<tr>
<td class="label">Atipamezole</td>
<td>Veterinary reversal</td>
</tr>
<tr>
<td class="label">Idazoxan</td>
<td>Research tool</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-4113b0e8" style="color:#ce93d8" title="Score: 0.47">Noradrenergic-Tau Propagation Blockade...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">94 edges</a></td>
</tr>
</table>

ADRA2A Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ADRA2A Gene</th>
</tr>
<tr>
<td class="label">Drug</td>
<td>Use</td>
</tr>
<tr>
<td class="label">Clonidine</td>
<td>Hypertension, ADHD</td>
</tr>
<tr>
<td class="label">Guanfacine</td>
<td>Hypertension, ADHD</td>
</tr>
<tr>
<td class="label">Dexmedetomidine</td>
<td>Sedation</td>
</tr>
<tr>
<td class="label">Brimonidine</td>
<td>Glaucoma</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Use</td>
</tr>
<tr>
<td class="label">Yohimbine</td>
<td>Reversal of α2 blockade</td>
</tr>
<tr>
<td class="label">Atipamezole</td>
<td>Veterinary reversal</td>
</tr>
<tr>
<td class="label">Idazoxan</td>
<td>Research tool</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-4113b0e8" style="color:#ce93d8" title="Score: 0.47">Noradrenergic-Tau Propagation Blockade...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">94 edges</a></td>
</tr>
</table>

Adra2A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The ADRA2A gene encodes the alpha-2A adrenergic receptor (alpha2A-AR), a G protein-coupled receptor that mediates the sympathetic nervous system's response to catecholamines. This receptor plays crucial roles in regulating blood pressure, heart rate, neurotransmitter release, and various autonomic functions. alpha2A-AR is a key therapeutic target for hypertension, ADHD, and analgesic medications.

Function

Normal Function

The α2A-adrenergic receptor has multiple physiological roles:

• Blood Pressure Regulation: Central sympathetic inhibition reduces vascular tone
• Norepinephrine Feedback: Autoreceptor function limits neurotransmitter release
• Pain Modulation: Spinal α2A-AR inhibits pain signal transmission
• Platelet Aggregation: Alpha-2A activation inhibits platelet activation
• Insulin Secretion: Modulates pancreatic beta-cell function
• Thermoregulation: Influences brown adipose tissue thermogenesis

Signaling Mechanisms

• G-Protein Coupling: Gi/o proteins inhibit adenylate cyclase
• cAMP Reduction: Decreased intracellular cAMP levels
• Ion Channel Modulation: Activation of inwardly rectifying K+ channels
• MAPK Pathways: Can activate ERK1/2 signaling

Expression Pattern

• Central Nervous System: Locus coeruleus, spinal cord dorsal horn, prefrontal [cortex](/brain-regions/cortex)
• Peripheral Tissues: Platelets, adipocytes, pancreatic islets
• Blood Vessels: Vascular smooth muscle cells

Disease Associations

Parkinson's Disease

• Dopamine Interaction: α2A-AR modulates dopaminergic transmission
• Levodopa-Induced Dyskinesia: α2A-AR antagonists may reduce LID
• Blood Pressure Dysregulation: Autonomic dysfunction in PD

Alzheimer's Disease

• Norepinephrine Signaling: Memory and attention modulation
• Neuroinflammation: α2A-AR regulates microglial activation
• Therapeutic Targeting: α2A-agonists show cognitive effects

Attention Deficit Hyperactivity Disorder (ADHD)

• Atomoxetine Target: Norepinephrine reuptake inhibition affects α2A signaling
• Prefrontal Function: Working memory and attention regulation
• Genetic Variants: ADRA2A polymorphisms associated with ADHD

Hypertension

• Central Action: Clonidine and guanfacine lower blood pressure
• Peripheral Vasodilation: Reduced sympathetic tone
• Reflex Tachycardia: Baroreflex modulation

Chronic Pain

• Spinal Analgesia: α2A-AR agonists (clonidine) used as adjuvants
• Neuropathic Pain: Efficacy in diabetic neuropathy and cancer pain
• Opioid Sparing: Reduces opioid requirements

Molecular Mechanisms

Receptor Structure

• Seven Transmembrane Domains: Classic GPCR architecture
• N-Terminal Extracellular Domain: Ligand binding
• C-Terminal Intracellular Domain: G-protein coupling and phosphorylation
• Disulfide Bond: Conserved cysteine bridge stabilization

Polymorphisms

• rs5538 (3' UTR): Associated with ADHD and hypertension
• rs1800544: Linked to drug response
• rs521491: Influences receptor expression

Therapeutic Targeting

Agonists

Antagonists

Animal Models

Knockout Studies

• ADRA2A knockout mice show elevated norepinephrine and blood pressure
• Phenotypes include increased heart rate and activity
• Helpful for understanding receptor function

Transgenic Models

• Overexpression models study receptor function
• Humanized mice for drug testing

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Norepinephrine](/entities/norepinephrine)
• [Sympathetic Nervous System](/entities/autonomic-nervous-system))
• [Locus Coeruleus](/cell-types/locus-coeruleus)
• [G Protein-Coupled Receptors](/entities/g-protein-coupled-receptors)
• [Pain Pathways](/mechanisms/pain-modulation)

External Links

• [NCBI Gene: ADRA2A](https://www.ncbi.nlm.nih.gov/gene/150)
• [UniProt: P08913](https://www.uniprot.org/uniprot/P08913)
• [IUPHAR/BPS Guide: α2A-AR](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=79)
• [OMIM: 104210](https://www.omim.org/entry/104210)

Background

The study of Adra2A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Noradrenergic-Tau Propagation Blockade](/hypothesis/h-4113b0e8) — <span style="color:#ffd54f;font-weight:600">0.47</span> · Target: ADRA2A